PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34157012-3	2021	Crizotinib has been effective in ALK and ROS1-positive IMTs but resistance eventually develops.	Crizotinib	0-10	ROS proto-oncogene 1, receptor tyrosine kinase	Homo sapiens	41-45